Publications by authors named "Conner Lambden"

Article Synopsis
  • The study investigates how the balance between T helper type 1 (T1) and other T cell types is maintained, which is crucial for effective antiviral and anti-tumor responses.
  • Researchers utilized a specialized culture system and CRISPR screens to uncover regulators that influence T cell differentiation, focusing on the role of RAMP3 and its interactions with the neuropeptide CGRP.
  • Findings reveal that after viral infection, neuron-produced CGRP enhances T1 and CD8 T cell responses via RAMP3, creating a neuroimmune circuit that aids in controlling acute viral infections.
View Article and Find Full Text PDF

CD8 T cells must persist and function in diverse tumor microenvironments to exert their effects. Thus, understanding common underlying expression programs could better inform the next generation of immunotherapies. We apply a generalizable matrix factorization algorithm that recovers both shared and context-specific expression programs from diverse datasets to a single-cell RNA sequencing (scRNA-seq) compendium of 33,161 CD8 T cells from 132 patients with seven human cancers.

View Article and Find Full Text PDF

Intestinal IL-17-producing T helper (Th17) cells are dependent on adherent microbes in the gut for their development. However, how microbial adherence to intestinal epithelial cells (IECs) promotes Th17 cell differentiation remains enigmatic. Here, we found that Th17 cell-inducing gut bacteria generated an unfolded protein response (UPR) in IECs.

View Article and Find Full Text PDF
Article Synopsis
  • Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer with limited treatment options, and current methods for understanding its molecular characteristics are inadequate.
  • Researchers used advanced techniques, including single-nucleus RNA sequencing and digital spatial profiling, to analyze 43 PDAC tumors, revealing key cellular subtypes and their interactions.
  • They identified new malignant cell programs linked to poor outcomes and established three distinct multicellular communities, providing insights that could improve patient stratification in clinical trials and guide targeted therapies.
View Article and Find Full Text PDF

Immune responses to cancer are highly variable, with mismatch repair-deficient (MMRd) tumors exhibiting more anti-tumor immunity than mismatch repair-proficient (MMRp) tumors. To understand the rules governing these varied responses, we transcriptionally profiled 371,223 cells from colorectal tumors and adjacent normal tissues of 28 MMRp and 34 MMRd individuals. Analysis of 88 cell subsets and their 204 associated gene expression programs revealed extensive transcriptional and spatial remodeling across tumors.

View Article and Find Full Text PDF

Interleukin-27 (IL-27) is an immunoregulatory cytokine that suppresses inflammation through multiple mechanisms, including induction of IL-10, but the transcriptional network mediating its diverse functions remains unclear. Combining temporal RNA profiling with computational algorithms, we predict 79 transcription factors induced by IL-27 in T cells. We validate 11 known and discover 5 positive (Cebpb, Fosl2, Tbx21, Hlx, and Atf3) and 2 negative (Irf9 and Irf8) Il10 regulators, generating an experimentally refined regulatory network for Il10.

View Article and Find Full Text PDF

CD137 (4-1BB) is a member of the TNFR superfamily that represents a promising target for cancer immunotherapy. Recent insights into the function of TNFR agonist antibodies implicate epitope, affinity, and IgG subclass as critical features, and these observations help explain the limited activity and toxicity seen with clinically tested CD137 agonists. Here, we describe the preclinical characterization of CTX-471, a fully human IgG4 agonist of CD137 that engages a unique epitope that is shared by human, cynomolgus monkey, and mouse and is associated with a differentiated pharmacology and toxicology profile.

View Article and Find Full Text PDF

Neuroimmune interactions have emerged as critical modulators of allergic inflammation, and type 2 innate lymphoid cells (ILC2s) are an important cell type for mediating these interactions. Here, we show that ILC2s expressed both the neuropeptide calcitonin gene-related peptide (CGRP) and its receptor. CGRP potently inhibited alarmin-driven type 2 cytokine production and proliferation by lung ILC2s both in vitro and in vivo.

View Article and Find Full Text PDF